Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Molecular Diagnostics and NAT market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Molecular Diagnostics and NATmarket, defines the market attractiveness level of Molecular Diagnostics and NAT market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Molecular Diagnostics and NAT industry, describes the types of Molecular Diagnostics and NAT market, the applications of major players and the market size, and deeply analyzes the current situation of the global Molecular Diagnostics and NAT market and the development prospects and opportunities of Molecular Diagnostics and NAT industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Molecular Diagnostics and NAT market in Chapter 13.
By Player:
Abbott
Thermo Fisher Scientific
Biomerieux
Roche
Agilent
AutoGenomics
Qiagen
Siemens Healthcare
BD
GenMark
By Type:
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing
By End-User:
Hospitals and Clinics
Research Institutes
Diagnostic Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Molecular Diagnostics and NAT Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Molecular Diagnostics and NAT Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Molecular Diagnostics and NAT Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Molecular Diagnostics and NAT Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Molecular Diagnostics and NAT Market Analysis and Outlook to 2022
-
7.1 Global Molecular Diagnostics and NAT Consumption (2017-2022)
-
7.2 United States Molecular Diagnostics and NAT Consumption (2017-2022)
-
7.3 Europe Molecular Diagnostics and NAT Consumption (2017-2022)
-
7.4 China Molecular Diagnostics and NAT Consumption (2017-2022)
-
7.5 Japan Molecular Diagnostics and NAT Consumption (2017-2022)
-
7.6 India Molecular Diagnostics and NAT Consumption (2017-2022)
-
7.7 South Korea Molecular Diagnostics and NAT Consumption (2017-2022)
8 Region and Country-wise Molecular Diagnostics and NAT Market Analysis and Outlook to 2028
-
8.1 Global Molecular Diagnostics and NAT Consumption Forecast (2022-2028)
-
8.2 United States Molecular Diagnostics and NAT Consumption Forecast (2022-2028)
-
8.3 Europe Molecular Diagnostics and NAT Consumption Forecast (2022-2028)
-
8.4 China Molecular Diagnostics and NAT Consumption Forecast (2022-2028)
-
8.5 Japan Molecular Diagnostics and NAT Consumption Forecast (2022-2028)
-
8.6 India Molecular Diagnostics and NAT Consumption Forecast (2022-2028)
-
8.7 South Korea Molecular Diagnostics and NAT Consumption Forecast (2022-2028)
9 Global Molecular Diagnostics and NAT Market Outlook by Types and Applications to 2022
-
9.1 Global Molecular Diagnostics and NAT Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Amplification Technologies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Amplified Gene Detection Technologies Consumption and Growth Rate (2017-2022)
-
9.1.3 Global DNA And Oligonucleotide Microarrays Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Gene Sequencing Consumption and Growth Rate (2017-2022)
-
9.2 Global Molecular Diagnostics and NAT Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
10 Global Molecular Diagnostics and NAT Market Outlook by Types and Applications to 2028
-
10.1 Global Molecular Diagnostics and NAT Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Amplification Technologies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Amplified Gene Detection Technologies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global DNA And Oligonucleotide Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Gene Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Molecular Diagnostics and NAT Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Molecular Diagnostics and NAT Import and Export Analysis (Top 5 Countries)
-
11.1 Global Molecular Diagnostics and NAT Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Molecular Diagnostics and NAT Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Molecular Diagnostics and NAT Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Molecular Diagnostics and NAT Market Competitive Analysis
-
14.1 Abbott
-
14.1.1 Abbott Company Details
-
14.1.2 Abbott Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Abbott Molecular Diagnostics and NAT Product and Service
-
14.2 Thermo Fisher Scientific
-
14.2.1 Thermo Fisher Scientific Company Details
-
14.2.2 Thermo Fisher Scientific Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Product and Service
-
14.3 Biomerieux
-
14.3.1 Biomerieux Company Details
-
14.3.2 Biomerieux Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biomerieux Molecular Diagnostics and NAT Product and Service
-
14.4 Roche
-
14.4.1 Roche Company Details
-
14.4.2 Roche Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Roche Molecular Diagnostics and NAT Product and Service
-
14.5 Agilent
-
14.5.1 Agilent Company Details
-
14.5.2 Agilent Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Agilent Molecular Diagnostics and NAT Product and Service
-
14.6 AutoGenomics
-
14.6.1 AutoGenomics Company Details
-
14.6.2 AutoGenomics Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AutoGenomics Molecular Diagnostics and NAT Product and Service
-
14.7 Qiagen
-
14.7.1 Qiagen Company Details
-
14.7.2 Qiagen Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Qiagen Molecular Diagnostics and NAT Product and Service
-
14.8 Siemens Healthcare
-
14.8.1 Siemens Healthcare Company Details
-
14.8.2 Siemens Healthcare Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Siemens Healthcare Molecular Diagnostics and NAT Product and Service
-
14.9 BD
-
14.9.1 BD Company Details
-
14.9.2 BD Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 BD Molecular Diagnostics and NAT Product and Service
-
14.10 GenMark
-
14.10.1 GenMark Company Details
-
14.10.2 GenMark Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GenMark Molecular Diagnostics and NAT Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Molecular Diagnostics and NAT
-
Figure Molecular Diagnostics and NAT Picture
-
Table Global Molecular Diagnostics and NAT Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Molecular Diagnostics and NAT Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Molecular Diagnostics and NAT Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Molecular Diagnostics and NAT Consumption by Country (2017-2022)
-
Figure United States Molecular Diagnostics and NAT Consumption and Growth Rate (2017-2022)
-
Table Europe Molecular Diagnostics and NAT Consumption and Growth Rate (2017-2022)
-
Figure China Molecular Diagnostics and NAT Consumption and Growth Rate (2017-2022)
-
Figure Japan Molecular Diagnostics and NAT Consumption and Growth Rate (2017-2022)
-
Figure India Molecular Diagnostics and NAT Consumption and Growth Rate (2017-2022)
-
Figure South Korea Molecular Diagnostics and NAT Consumption and Growth Rate (2017-2022)
-
Figure Global Molecular Diagnostics and NAT Consumption Forecast by Country (2022-2028)
-
Figure United States Molecular Diagnostics and NAT Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Molecular Diagnostics and NAT Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Molecular Diagnostics and NAT Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Molecular Diagnostics and NAT Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Molecular Diagnostics and NAT Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Molecular Diagnostics and NAT Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amplification Technologies Consumption and Growth Rate (2017-2022)
-
Figure Global Amplified Gene Detection Technologies Consumption and Growth Rate (2017-2022)
-
Figure Global DNA And Oligonucleotide Microarrays Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Amplification Technologies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amplified Gene Detection Technologies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DNA And Oligonucleotide Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Molecular Diagnostics and NAT Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Molecular Diagnostics and NAT Export by Region (Top 5 Countries) (2017-2028)
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Molecular Diagnostics and NAT Product and Service
-
Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Molecular Diagnostics and NAT Product and Service
-
Table Biomerieux (Foundation Year, Company Profile and etc.)
-
Table Biomerieux Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biomerieux Molecular Diagnostics and NAT Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Molecular Diagnostics and NAT Product and Service
-
Table Agilent (Foundation Year, Company Profile and etc.)
-
Table Agilent Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Molecular Diagnostics and NAT Product and Service
-
Table AutoGenomics (Foundation Year, Company Profile and etc.)
-
Table AutoGenomics Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table AutoGenomics Molecular Diagnostics and NAT Product and Service
-
Table Qiagen (Foundation Year, Company Profile and etc.)
-
Table Qiagen Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen Molecular Diagnostics and NAT Product and Service
-
Table Siemens Healthcare (Foundation Year, Company Profile and etc.)
-
Table Siemens Healthcare Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Healthcare Molecular Diagnostics and NAT Product and Service
-
Table BD (Foundation Year, Company Profile and etc.)
-
Table BD Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table BD Molecular Diagnostics and NAT Product and Service
-
Table GenMark (Foundation Year, Company Profile and etc.)
-
Table GenMark Molecular Diagnostics and NAT Sales, Price, Value and Gross Profit (2017-2022)
-
Table GenMark Molecular Diagnostics and NAT Product and Service
-
